Exelixis News - Mon, jan 9, 2023, 10:33 am 5 min read. Thursday, exelixis inc (nasdaq:exel) announced that the alliance for clinical trials in oncology. Exel) today announced the initiation of. Web zacks equity research. Exel) and insilico medicine (“insilico”).
Mon, jan 9, 2023, 10:33 am 5 min read. Exel) today announced the initiation of. Exel) and insilico medicine (“insilico”). Web zacks equity research. Thursday, exelixis inc (nasdaq:exel) announced that the alliance for clinical trials in oncology.